Phase III, randomized, double blind, placebo (P)-controlled trial of sorafenib (S) in desmoid tumor, (DT) (ALLIANCE A091105)
- Citation:
- J Clin Oncol vol 36 (no. 15_suppl) 11500-11500
- Meeting Instance:
- ASCO 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2964
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA077202, U10CA180820, U10CA180888, U24CA196171
- Corr. Author:
- Authors:
- Mrinal M. Gounder Michelle R. Mahoney Brian Andrew Van Tine Vinod Ravi Steven Attia Hari Anant Deshpande Abha A. Gupta Mohammed M. Milhem Robert Martin Conry Sujana Movva Michael J. Pishvaian Jeffrey Crawford Tarek Sabagh Robert G. Maki William D. Tap Robert A Lefkowitz Narasimhan P Agaram John Joseph Wright Amylou C. Dueck Gary K. Schwartz
- Networks:
- COLUMBIA, IA018, LAPS-CT018, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-NY016, LAPS-TX035, OH084
- Study
- Alliance-A091105
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: